首页> Clinical pharmacology and therapeutics> Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease.

Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease.

导出 OA

翻译打印收藏纠错

第一作者： Ye,Xiong

第一单位： Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

作者： Ye,Xiong ^[1] ; Tomoyuki,Mizuno ^[2] ; Ruben,Colman ^[3] ; Jeffrey,Hyams ^[4] ; Joshua D,Noe ^[5] ; Brendan,Boyle ^[6] ; Yi-Ting,Tsai ^[3] ; Min,Dong ^[2] ; Kimberly,Jackson ^[3] ; Nieko,Punt ^[7] ; Michael J,Rosen ^[8] ; Lee A,Denson ^[8] ; Alexander A,Vinks ^[2] ; Phillip,Minar ^[8]

作者单位： Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. ^[1] Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.;Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. ^[2] Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. ^[3] Connecticut Children's Medical Center, Hartford, Connecticut, USA. ^[4] Medical College of Wisconsin, Milwaukee, Wisconsin, USA. ^[5] Nationwide Children's Hospital, Columbus, Ohio, USA. ^[6] Medimatics, Maastricht, The Netherlands. ^[7] Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.;Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. ^[8]